Ram Mahato

14PUBLICATIONS
21CO-AUTHORS
Molecular targetsCharacterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesWastewater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 13, 2025
Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment.

Jingyi Ma, Dalton W Staler, Ram I Mahato

|Jul 31, 2025
Pharmacokinetics and Biodistribution of Polymeric Nanoparticles Loaded with a Small Molecule Drug in Mice with Alcoholic Liver Disease.

Jingyi Ma, Qiaoyu Pan, Sohan Mahto

|Jul 01, 2024
A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases.

Dalton W Staller, Sanjali S Panigrahi, Yahani P Jayasinghe

|May 30, 2024
Gemcitabine-Lipid Conjugate and ONC201 Combination Therapy Effectively Treats Orthotopic Pancreatic Tumor-Bearing Mice.

Prakash Shrestha, Yashwardhan Ghanwatkar, Sohan Mahto

|Apr 27, 2024
Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression.

Natalia A Osna, Irina Tikhanovich, Martí Ortega-Ribera

|Mar 30, 2024
Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model.

Virender Kumar, Bharti Sethi, Dalton W Staller

Pageof 3

Frequent Collaborators

2 joint publications

Virender Kumar

1 joint publications

Deepak Chitkara

1 joint publications

Guofeng Cheng

1 joint publications

Lifang Yin